Skip to main content
. 2020 Sep 17;107(4):636–653. doi: 10.1016/j.ajhg.2020.08.014

Figure 4.

Figure 4

Plots of Phenotype-Specific Replication Enrichment Ratios and Respective 95% Confidence Intervals in SJLIFE Samples Unexposed or Exposed to Treatments

Treatments were defined as cancer treatments associated with phenotypes. Phenotypes with any evidence of replication depletion (RER < 1) in our main analysis that showed either significant (p < 0.05) or suggestive (p < 0.2) replication depletion in SJLIFE treatment-exposed samples are included in this figure. Sample sizes by exposure strata (NTX-, No Treatment; NTX+, Treatment) are provided, as well as likelihood ratio test p values representing treatment associations with phenotypes (PTX) and incremental changes in adjusted R2 (ΔRTX2) after removing treatment variables from clinical models. Phenotypes are ordered based on ΔRTX2 values, with larger ΔRTX2 values reflecting greater treatment influence on phenotype variation.